The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance
Open accessAbstract
BACKGROUND: Recent reports have demonstrated a decline in bacterial bloodstream infections (BSIs) following adherence to central line insertion practices; however, declines have been less evident for BSIs due to Candida species. METHODS: We conducted active, population-based laboratory surveillance for candidemia in metropolitan Atlanta, GA and Baltimore, MD over a 5-year period. We calculated annual candidemia incidence and antifungal drug resistance rates. RESULTS: We identified 3,848 candidemia cases from 2008-2013. Compared with 2008, candidemia incidence per 100,000 person-years decreased significantly by 2013 in both locations (GA: 14.1 to 9.5, p<0.001; MD: 30.9 to 14.4, p<0.001). A total of 3,255 cases (85%) had a central venous catheter (CVC) in place within 2 days before the BSI culture date. In both locations, the number of CVC-associated cases declined (GA: 473 to 294; MD: 384 to 151). Candida albicans (CA, 36%) and Candida glabrata (CG, 27%) were the most common species recovered. In both locations, the proportion of cases with fluconazole resistance decreased (GA: 8.0% to 7.1%, -10%; MD: 6.6% to 4.9%, -25%), while the proportion of cases with an isolate resistant to an echinocandin increased (GA: 1.2% to 2.9%, +147%; MD: 2.0% to 3.5%, +77%). Most (74%) echinocandin-resistant isolates were CG; 17 (<1%) isolates were resistant to both drug categories (multidrug resistant [MDR], 16/17 were CG). The proportion of CG cases with MDR Candida increased from 1.8% to 2.6%. CONCLUSIONS: We observed a significant decline in the incidence of candidemia over a five-year period, and increases in echinocandin-resistant and MDR Candida. Efforts to strengthen infection control practices may be preventing candidemia among high-risk patients. Further surveillance for resistant Candida is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings from EIP surveillance data have indicated a decrease in overall candidemia incidence in their longest-running surveillance sites of Atlanta, GA, and Baltimore, MD, with the incidence of all species decreasing except C. tropicalis [8].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A more nuanced assessment using data from active population-based surveillance showed the incidence of candidemia decreased from 2008 to 2017 across multiple US sites,25,27,35 with a coincident increase in the incidence of IC from non-blood sources, including abdominal sterile sites, from 2009–2017.34”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In population-based surveillance performed in the metropolitan areas of Atlanta, Georgia, and Baltimore, Maryland, candidemia incidence (primarily among adults) increased 10%–40% from the early 1990s and the late 2000s, which was followed by more recent reports of decreases in these areas (6,28–30).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This contrasts with data from the early 1990s, when infants had the highest incidence (6), followed by substantial decreases by the late 2000s (26,28).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although C. glabrata has been reported to represent more than 30% of the non-albicans Candida in some geographic areas [4, 6–9].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Population-based surveillance in two U.S. metropolitan areas found that annual candidemia incidence per 100,000 population declined during 2008–2013 (from 14.1 to 9.5 in Atlanta and 30.9 to 14.4 in Baltimore), likely because of improved infection prevention and control practices (17).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [17]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Limited data from resource-limited settings suggest that timely administration of antimicrobials in patients with sepsis and septic shock is beneficial and potentially feasible (121-126).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [122]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The percentage of Black patients affected by candidemia increased during the study period, likely mirroring the disproportionate effect of the COVID-19 pandemic on Black patients (3,17,25).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“Candida strains with acquired resistance to echinocandins, specifically C. glabrata, while still generally infrequent, are increasing in incidence in some hospitals [10,14].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [10]
In the citing paper
“Specifically, C. glabrata has become an important pathogen in North America, Europe (with the exception of Spain), and Australia, whereas C. parapsilosis is the dominant non-albicans species in South America, Japan, and Spain [8,9,10].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [10]
In the citing paper
“The use of echinocandins and development of cross-resistance is creating apprehension, for the signs of multidrug resistance amongst azoles and echinocandins have already been described [168,169,170].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R., Roth, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061115 · Cited by 4,387
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Health Care–Associated Infections
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C. A., Denham, C. R., & Bates, D. W. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9763 · Cited by 1,927
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Vital Signs: Central Line–Associated Blood Stream Infections—United States, 2001, 2008, and 2009
Liang, S. Y., & Marschall, J. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.07.035 · Cited by 471
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Self-citationCleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366
Self-citationSchulman, J. D., Stricof, R. L., Stevens, T. P., Horgan, M. J., Gase, K., Holzman, I. R., Koppel, R. I., Nafday, S. M., Gibbs, K., Angert, R. M., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2873 · Cited by 313
Flagged first, then by citations
Research works printed but not linked: 1
- J Schulman, 2011, Statewide NICU Central-Line-Associated Bloodstream Infection Rates Decline After Bundles and Checklists, Pediatrics, 127, 436, 10.1542/peds.2010-2873 · DOI
Cited by
Sorted by citations
Items 101–200 of 305
Massa, N., Cantamessa, S., Novello, G., Ranzato, E., Martinotti, S., Pavan, M., Rocchetti, A., Berta, G., Gamalero, E., & Bona, E. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2018-0082 · Cited by 31
Pereira, F., & Rammaert, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00230-5 · Cited by 30
Valotteau, C., Prystopiuk, V., Cormack, B. P., & Dufrêne, Y. F. (2019) · mSphere · doi:10.1128/msphere.00277-19 · Cited by 30
Cell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata
Xu, Z., Green, B., Benoit, N. E., Sobel, J. D., Schatz, M. C., Wheelan, S. J., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 28
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 35
Invasive Candidiasis: Epidemiology and Risk Factors
Cortés, J. A., & Corrales, I. F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81813 · Cited by 28
Galgóczy, L., Yap, A., & Marx, F. (2019) · Israel Journal of Chemistry · doi:10.1002/ijch.201800168 · Cited by 26
Kord, M., Salehi, M., Khodavaisy, S., Hashemi, S. J., Ghazvini, R. D., Rezaei, S., Maleki, A., Elmimoghaddam, A., Alijani, N., Abdollahi, A., et al. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001189 · Cited by 28
Teo, J. Q.-M., Candra, S. R., Lee, S. J.-Y., Chia, S. Y.-H., Leck, H., Tan, A., Neo, H.-P., Leow, K. W.-L., Cai, Y., Ee, P. L. R., et al. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0184-1 · Cited by 27
Keane, S., Geoghegan, P., Póvoa, P. M. S. R., Nseir, S., Rodríguez, A. H., & Martín‐Loeches, I. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1528872 · Cited by 27
Silva, L. N., de Mello, T. P., Ramos, L. S., Branquinha, M. H., & dos Santos, A. L. S. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025152412 · Cited by 27
Piqueras, A., Ganapathi, L., Carpenter, J. F., Rubio, T. T., Sandora, T. J., Flett, K. B., & Köhler, J. R. (2021) · Journal of Fungi · doi:10.3390/jof7020078 · Cited by 25
Hamzavi, S. S., Amanati, A., Badiee, P., Kadivar, M. R., Jafarian, H., Ghasemi, F. S., Haghpanah, S., Dehghani, M., & Baghani, A. N. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4372-x · Cited by 26
Antifungal stewardship: What we need to know
Ray, A., Das, A., & Panda, S. (2022) · Indian Journal of Dermatology Venereology and Leprology · doi:10.25259/ijdvl_91_2022 · Cited by 25
Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infections
Ramakrishnan, J., Rathore, S. S., & Raman, T. (2016) · RSC Advances · doi:10.1039/c6ra01577h · Cited by 27
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital
Battistolo, J., Glampedakis, E., Damonti, L., Poissy, J., Grandbastien, B., Kalbermatter, L., Pagani, J., Eggimann, P., Bochud, P., Calandra, T., et al. (2021) · Mycoses · doi:10.1111/myc.13376 · Cited by 26
Azim, A., Ahmed, A., & Marak, R. S. K. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1514201 · Cited by 24
Detection of ERG11 point mutations in Iranian fluconazoleresistant Candida albicans isolates
Sardari, A., Zarrinfar, H., & Mohammadi, R. (2019) · Current Medical Mycology · doi:10.18502/cmm.5.1.531 · Cited by 23
Transcriptomics Analysis of Candida albicans Treated with Huanglian Jiedu Decoction Using RNA‐seq
Yang, Q., Gao, L., Tao, M., Chen, Z., Yang, X., & Cao, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3198249 · Cited by 22
McCarty, T. P., Lockhart, S. R., Moser, S. A., Whiddon, J., Zurko, J., Pham, C. D., & Pappas, P. G. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky059 · Cited by 21
Self-citationFungal Infections of the Central Nervous System
Jia, D. T., & Thakur, K. T. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1688916 · Cited by 22
Epidemiología de las micosis invasoras: un paisaje en continuo cambio
Quindós, G. (2018) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2018.07.002 · Cited by 25
Alobaid, K., & Khan, Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.12.001 · Cited by 21
Yeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20
Pongrácz, J., Juhász, E., Iván, M., & Kristóf, K. (2015) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.62.2015.3.9 · Cited by 20
Suzuki, H., Perencevich, E. N., Diekema, D. J., Livorsi, D. J., Nair, R., Kralovic, S. M., Roselle, G. A., & Goto, M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab105 · Cited by 20
Toepfer, S., Lackner, M., Keniya, M. V., & Monk, B. C. (2023) · Journal of Fungi · doi:10.3390/jof9020168 · Cited by 19
Meneghello, S., Bernabé, G., Pietra, G. D., Sopra, S. D., Vecchio, C. D., Cattelan, A. M., Castagliuolo, I., & Brun, P. (2024) · Journal of Fungi · doi:10.3390/jof10100707 · Cited by 20
Deciphering the oxidative stress response in Candida albicans
Arribas, V., Gil, C., & Molero, G. (2025) · Fungal Biology Reviews · doi:10.1016/j.fbr.2025.100427 · Cited by 20
Morales-López, S. E., Dudiuk, C., Vivot, W., Szusz, W., Córdoba, S. B., & García‐Effrón, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00170-17 · Cited by 18
Kothalawala, M., Jayaweera, J. A. A. S., Arunan, S., & Jayathilake, A. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1518-3 · Cited by 18
Sikora, M., Kuthan, R., Piskorska, K., Gołaś-Prądzyńska, M., Domański, D., AUGUSTYNOWICZ-KOPEĆ, E. M., & Swoboda‐Kopeć, E. (2019) · Polish Journal of Microbiology · doi:10.33073/pjm-2019-032 · Cited by 18
Bretagne, S., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Che, D., Dromer, F., & YEASTS, P. O. T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641965 · Cited by 18
Impact of a candidaemia care bundle on patient care at a large teaching hospital in England
Gouliouris, T., Micallef, C., Yang, H., Aliyu, S. H., Kildonaviciute, K., & Enoch, D. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.01.008 · Cited by 18
Rossow, J. A., Gharpure, R., Brennan, J., Relan, P., Williams, S. R., Vallabhaneni, S., Jackson, B. R., Graber, C. R., Hillis, S. R., Schaffner, W., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa024 · Cited by 17
Ding, L., Li, T., Bai, C., Zhang, Q., Li, Z., & Li, X. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05780-x · Cited by 17
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris
Toepfer, S., Keniya, M. V., Lackner, M., & Monk, B. C. (2024) · Journal of Fungi · doi:10.3390/jof10100698 · Cited by 18
Marinelli, T. M., Pennington, K. M., Hamandi, B., Donahoe, L. L., Rotstein, C., Martinu, T., & Husain, S. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13812 · Cited by 16
Taj‐Aldeen, S. J., Salah, H., Perez, W. B., Almaslamani, M., Motyl, M. R., AbdulWahab, A., Healey, K. R., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00214-18 · Cited by 16
Fais, R., Rizzato, C., Franconi, I., Tavanti, A., & Lupetti, A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01240-22 · Cited by 15
Maliszewska, I., Wanarska, E., & Tylus, W. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.102016 · Cited by 15
Detection of Candida albicans Using a Manufactured Electrochemical Sensor
Dutta, P., Lu, Y.-J., Hsieh, H., Lee, T.-Y., Lee, Y., Cheng, C., & Fan, Y. (2021) · Micromachines · doi:10.3390/mi12020166 · Cited by 15
Hii, I.-M., Liu, C.-E., Lee, Y.-L., Liu, W., Wu, P.-F., Hsieh, M.-H., Ho, M., Chen, Y., & Wang, F. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s184884 · Cited by 15
Vallabhaneni, S., Sapiano, M., Weiner, L. M., Lockhart, S. R., & Magill, S. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx175 · Cited by 14
Self-citationEllagic Acid Potentiates the Inhibitory Effects of Fluconazole Against Candida albicans
Mendes, A. G. G., Campos, C. D. L., Filho, J. L. P., Pereira, A. P. A., Reis, G. S. A., Araújo, Á. W. M. D. S., Monteiro, P. D. M., Vidal, F. C. B., Monteiro, S. G., Figueiredo, I. F. D. S., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13121174 · Cited by 14
Evolution and Application of Inteins in Candida species: A Review
Fernandes, J. A. L., Prandini, T. H. R., Castro, M. D. C. A., Arantes, T. D., Giacobino, J., Bagagli, E., & Theodoro, R. C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01585 · Cited by 14
Dao, V. H., Ourliac‐Garnier, I., Bazin, M., Jacquot, C., Baratte, B., Ruchaud, S., Bach, S., Grovel, O., Pape, P. L., & Marchand, P. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.044 · Cited by 14
Candidaemia in Central Slovenia: A 12‐year retrospective survey
Matos, T., Zupanc, T. L., Škofljanec, A., Jazbec, A., Matos, E., Vodičar, P. M., Germ, J., Ciglar, T., Tomazin, R., Kofol, R., et al. (2021) · Mycoses · doi:10.1111/myc.13278 · Cited by 15
Amanati, A., Badiee, P., Jafarian, H., Ghasemi, F. S., Nematolahi, S., Haghpanah, S., & Hamzavi, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93421-3 · Cited by 14
Polat, S. H., Sharifynia, S., Öz, Y., Aslan, M., Gündoğdu, N., Serin, A., Rafati, H., Mohammadi, F., Metin, D. Y., Döğen, A., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0261-x · Cited by 14
Aşkun, T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100869 · Cited by 15
You, L., Yao, C., Yang, F., Yang, Q., Lan, J., Song, X., Shen, J., Sheng, X., Chen, X., Tang, H., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s258744 · Cited by 13
Filler, E. E., Liu, Y., Solis, N. V., Wang, L., Diaz, L. F., Edwards, J. E., Filler, S. G., & Yeaman, M. R. (2020) · Infection and Immunity · doi:10.1128/iai.00146-20 · Cited by 13
A Candida parapsilosis Overexpression Collection Reveals Genes Required for Pathogenesis
Pál, S. E., Tóth, R., Nosanchuk, J. D., Vágvölgyi, C., Németh, T., & Gácser, A. (2021) · Journal of Fungi · doi:10.3390/jof7020097 · Cited by 14
Witteman, L., van Wietmarschen, H., & van der Werf, E. T. (2021) · Antibiotics · doi:10.3390/antibiotics10030250 · Cited by 15
Prediction of novel and potent inhibitors of lanosterol 14-α demethylase
Waseem, M., Thakur, J. K., & Subbarao, N. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2096116 · Cited by 14
Catechin potentiates the antifungal effect of miconazole in Candida glabrata
Hervay, N. T., Eliaš, D., Habová, M., Jacko, J., Morvová, M., & Gbelská, Y. (2023) · Folia Microbiologica · doi:10.1007/s12223-023-01061-z · Cited by 18
The role of virulence factors inCandida albicanspathogenicity
Wibawa, T. (2016) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci004801201606 · Cited by 13
Molinaro, F., Tyc, O., Beekwilder, J., Cankar, K., Bertea, C. M., Nègre, M., & Garbeva, P. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny001 · Cited by 14
Identification and Characterization of a Neutral Locus for Knock-in Purposes in C. parapsilosis
Németh, T., Papp, C., Vágvölgyi, C., Chakraborty, T., & Gácser, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01194 · Cited by 13
Ergon, M. C., Dereli, M. D., Ener, B., Atalay, M. A., Koç, A. N., Çerikçioğlu, N., Erturan, Z., & Aksaray, S. (2020) · Mikrobiyoloji Bulteni · doi:10.5578/mb.69837 · Cited by 13
Wu, J., Gan, C., Li, J., Liu, Y., Chen, Z., Zhang, Y., Yi, G., Sui, J., & Xu, J. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s316368 · Cited by 13
Bona, E., Arrais, A., Ludovica, G., Perotti, V., Debora, B., Massa, N., Novello, G., & Gamalero, E. (2019) · Natural Product Research · doi:10.1080/14786419.2019.1696327 · Cited by 12
Jan, H.-E., Lo, C.-L., Lee, J., Li, M.-C., Lin, W.-L., Ko, W., & Lee, N. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.08.014 · Cited by 11
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida
Winkler, M., Rhomberg, P. R., Klauer, A., Edeker, S., & Castanheira, M. (2024) · Mycoses · doi:10.1111/myc.70001 · Cited by 11
Häring, M., Amann, V., Kissmann, A., Herberger, T., Synatschke, C. V., Kirsch-Pietz, N., Perez‐Erviti, J. A., Otero‐González, A. J., Morales-Vicente, F., Andersson, J., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071332 · Cited by 12
Wang, T., Hung, C., Shie, S., Chou, P.-C., Kuo, C.-H. S., Chung, F., Lo, Y.-L., & Lin, S. (2016) · Medicine · doi:10.1097/md.0000000000003834 · Cited by 12
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
Bels, D. D., Maillart, E., Françoise Van Bambeke, A., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 12
Limosilactobacillus fermentum Limits Candida glabrata Growth by Ergosterol Depletion
Zangl, I., Beyer, R., Gattesco, A., Labuda, R., Pap, I.-J., Strauss, J., & Schüller, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03326-22 · Cited by 10
McCann, S. M., Sinha, J., Wilson, W. S., McKinzie, C. J., Garner, L. M., & González, D. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01254-2 · Cited by 10
A Comprehensive Review of Identification Methods for Pathogenic Yeasts: Challenges and Approaches
Morovati, H., Kord, M., Ahmadikia, K., Eslami, S., Hemmatzadeh, M., Kurdestani, K. M., Khademi, M., & Darabian, S. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_375_22 · Cited by 10
Yakut, N., Kepenekli, E., Ergenç, Z., Baran, E., & Çerikçioğlu, N. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101082 · Cited by 10
Codon usage bias analysis of mitochondrial protein-coding genes in 12 species of Candida
Wang, F., Zhang, N., Zhao, C., Song, Z., & Xin, C. (2023) · Journal of Genetics · doi:10.1007/s12041-023-01434-w · Cited by 10
López, A. D. L. R., Lee, M., Wang, N., Dunn, K. K., Sánchez, H., Raman, N., Andes, D. R., Lynn, D. M., & Palecek, S. P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02653-18 · Cited by 10
Snails as Taxis for a Large Yeast Biodiversity
Akan, M., Michling, F., Matti, K., Krause, S., Muno-Bender, J., & Wendland, J. (2020) · Fermentation · doi:10.3390/fermentation6030090 · Cited by 10
Synergistic effect of tea tree oil on fungi causing vaginal thrush in pregnant women
Dahham, M. T., Omar, A. A. F., & Dheeb, B. I. (2019) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2019.13.2.579 · Cited by 10
Liu, S. H., Mitchell, H., & Al‐Rawahi, G. N. (2023) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2022-0021 · Cited by 10
Zhao, J.-T., Chen, K.-Z., Liu, J.-Y., Li, W.-H., Wang, Y.-Z., Wang, L.-L., & Xiang, M.-J. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00703-7 · Cited by 9
Unresolved issues in the diagnosis of catheter related candidemia: A position paper
Soriano-Martín, A., Muñóz, P., García‐Rodríguez, J., Cantón, R., Vena, A., Bassetti, M., & Bouza, E. (2023) · Revista Española de Quimioterapia · doi:10.37201/req/112.2023 · Cited by 10
Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county
Klingspor, H. T., & Hällgren, A. (2024) · Mycoses · doi:10.1111/myc.13758 · Cited by 9
Junco, S. J., Chehab, S., Giancarelli, A., Bowman, M. C., & Turner, R. B. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211018722 · Cited by 9
Ermenlieva, N. (2022) · FARMACIA · doi:10.31925/farmacia.2022.4.18 · Cited by 9
Invasive Esophageal Candidiasis with Chronic Mediastinal Abscess and Fatal Pneumomediastinum
Aghdam, M. R. F., & Sund, S. (2016) · American Journal of Case Reports · doi:10.12659/ajcr.898053 · Cited by 10
Ssa1-targeted antibody prevents host invasion by Candida albicans
Qiu, X.-R., Shen, C.-R., Jiang, L., Ji, P., Zhang, Y., Hou, W.-T., Zhang, W., Shen, H., & An, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1182914 · Cited by 10
Soriano-Martín, A., Escribano, P., Machado, M., Guinea, J., Reigadas, E., García-Clemente, P., Bouza, E., & Muñóz, P. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf359 · Cited by 8
Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis
Yang, Z., Zhang, F., Li, D., Wang, S., Pang, Z., Chen, L., Li, R., & Shi, D. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s387675 · Cited by 8
Antimicrobial potential of Indian Cinnamomum species
Singh, B., Nathawat, S., & Sharma, R. A. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.103549 · Cited by 10
Epidemiology of candidemia at a tertiary Canadian hospital, 2004–2013
Remington, T. L., Isaac, A., Vickers, D., Fuller, J., & Smith, S. W. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.3.1.04 · Cited by 8
The use of echinocandins in hospitalized children in the United States
Downes, K. J., Ellis, D. E., Lavigne, S. H., Bryan, M. W., Zaoutis, T. E., & Fisher, B. T. (2018) · Medical Mycology · doi:10.1093/mmy/myy084 · Cited by 8
Resistance of Candida albicans to antifungal drugs in Abidjan (Cote dIvoire)
C., G. K.-Y., N., A. D. A., A., V. B.-I., G., S. P. D., K., H. G. S., K., D. Z., K., D. A., & Dosso, M. B. (2020) · African Journal of Microbiology Research · doi:10.5897/ajmr2018.8817 · Cited by 7
Lin, C.-J., Yang, S.-Y., Hsu, L.-H., Yu, S.-J., & Chen, Y.-L. (2023) · Medical Mycology · doi:10.1093/mmy/myad004 · Cited by 7
Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
Zhao, H., Qin, L., Li, M., Jiang, M., Cui, M., Wang, H., Hou, B., Wang, F., & Jia, K. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1062 · Cited by 6
Heterogeneity of Candida bloodstream isolates in an academic medical center and affiliated hospitals
Scott, N. E., Wash, E., Zajac, C., Erayil, S. E., Kline, S. E., & Selmecki, A. M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00464-25 · Cited by 6
Multi-Omics Profiling of Candida albicans Grown on Solid Versus Liquid Media
Alhameed, R. A., Semreen, M. H., Hamad, M., Giddey, A. D., Sulaiman, A., Bataineh, M. T. A., Al-Hroub, H. M., Bustanji, Y. K., Alzoubi, K. H., & Soares, N. C. (2023) · Microorganisms · doi:10.3390/microorganisms11122831 · Cited by 7
Madduri, M., Rudramurthy, S. M., & Roy, U. (2024) · Acta Biochimica Polonica · doi:10.3389/abp.2024.11999 · Cited by 7
Farah, N., Lim, C. W., Chin, V. K., Chong, P. P., Basir, R., Yeo, W. W. Y., Tay, S. T., Choo, S., & Lee, T. Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106665 · Cited by 7
Espinel‐Ingroff, A., & Dannaoui, É. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00378-3 · Cited by 7
Emerging and Re-emerging Fungal Infections
Francesconi, F., Francesconi, V. A., Lupi, O., & Khalfe, Y. (2021) · Updates in clinical dermatology · doi:10.1007/978-3-030-68321-4_9 · Cited by 6
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris
Raschig, M., Ramı́rez-Zavala, B., Wiest, J. M., Saedtler, M., Gutmann, M., Holzgrabe, U., Morschhäuser, J., & Meinel, L. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200463 · Cited by 6
Wang, R., Jiang, A., Zhang, R., Shi, C., Ding, Q., Liu, S., Zhao, F., Ma, Y., Liu, J., Fu, X., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08447-x · Cited by 6
Metadata
- Authors
- Cleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., & Park, B. J.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Emory University (US)
- Corresponding author
- Cleveland, Angela Ahlquist
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-30
- Volume
- 10
- Issue
- 3
- Pages
- e0120452
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4378850
- OpenAlex
- W2044502735
- Cited by
- 304
- References
- 26
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 21 · 2023: 28 · 2022: 31 · 2021: 27 · 2020: 32 · 2019: 36 · 2018: 31 · 2017: 31 · 2016: 28 · 2015: 11
- FWCI
- 26.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- candidemia, candidemia incidence, antifungal resistance, echinocandin resistance, fluconazole resistance, Candida glabrata, Candida albicans, multidrug resistance, central venous catheters, bloodstream infection, infection control, Atlanta, Baltimore, population-based surveillance, central line-associated bloodstream infection
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida, Child, Child, Preschool, Female, Georgia, Humans, Infant, Infant, Newborn, Male, Microbial Sensitivity Tests, Middle Aged, Population Surveillance, Baltimore, Incidence, Drug Resistance, Fungal, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
